Statement regarding Cambodian NHP supply

The November 16, 2022, indictment filed against the Cambodian breeder and Cambodian officials does not name or reference Labcorp. The Early Development business has multiple global suppliers and requires its vendors to meet high regulatory compliance standards. Ex-US sites do not use Cambodian NHP supply. The business is working to procure additional supply from other sources for our US operations. US NHP studies comprise less than 2% of overall enterprise Labcorp revenue.

About Labcorp
Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. With over 75,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $16 billion in FY2021. Learn more about us at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp.

Labcorp Contacts: 

Media: Rachael Valdez – 336-436-8263 
[email protected]

Investors: Chas Cook – 336-436-5076 
[email protected]